Year Established :
2007
Total Assets(USD) :
choose not to disclose
Total Number of Staff :
less than 10 person
Other Competitive Advantages :
Own GMP in some APIs' products;
Mass production in workshop;
Serious to control the quality of product;
Best quality and High speed feedback of Customers Service.
Patents and Copyrights :
Patents:
Biapenem Intermediates
preparation method of 6,7-Dihydro-6-mercapto-5H-pyrazolo[1,2-a][1,2,4]triazolium chloridePreparation method of Cefoselis Hydrogen Sulfate
The industrial capability of prulifloxacin
Business Type :
Manufacturer,Trading Company
Annual Turnover(USD) :
choose not to disclose
Main Sales Markets :
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Main Product Categorise :
Active Pharmaceutical Ingredients,Intermediates
Product Range :
API and Intermediates:
Rosuvastatin calcium, Atorvastatin Calcium, Adefovir dipivoxil, Adefovir, Entecavir, Solifenacin succinate, Gefitinib, Erlotinib Hydrochloride, Sunitinib malate, Dasatinib, Biapenem, Doripenem, Triptan and so on.